Drug Trial Radar · NCT05645536
Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study
Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
250
Planned (sponsor's estimate)
Start
Dec 28, 2022
Primary completion
Mar 2030
Study completion Mar 2030
Sponsor
- Lead sponsor
- Tolmar Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 9, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 51 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
TOL2506A (OVELIA) is a Phase 3, single arm, open-label study evaluating the effectiveness of TOL2506 in suppressing ovarian function in premenopausal women with HR+, HER2-negative breast cancer and men with HR+ breast cancer. The TOL2506A-EXT study described here is a safety extension study to assess and collect long-term data on the ongoing safety and tolerability of TOL2506 in combination with tamoxifen or an AI for up to 4 years.
Conditions
- Breast Cancer
Interventions
TOL2506Drug
Leuprolide Acetate for injectable suspension, 30 mg. Subcutaneous injection every 3 months
TamoxifenDrug
20 mg once daily or 10 mg 2 times daily - either tablet of solution
Letrozole tabletsDrug
One 2.5 mg tablet taken orally once daily
Anastrozole TabletsDrug
One 1 mg tablet taken orally once daily
Exemestane TabletsDrug
One 25 mg tablet taken orally once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- The occurrences of treatment-emergent adverse events (TEAEs) and serious adverse events (SAEs)Time frame: 4 years from enrolling in study
Locations
46 sites in 6 countries. Site status is shown where the registry gives one.
Marin Cancer Care, Inc.
Greenbrae, California
Holy Cross Hospital
Fort Lauderdale, Florida
Baptist Health Lexington
Lexington, Kentucky
Baptist Health Louisville
Louisville, Kentucky
Maryland Oncology Hematology, P.A.
Columbia, Maryland
Hematology Oncology Associates of Central New York, PC
East Syracuse, New York
Cape Fear Valley Health Systems - Cancer Center
Fayetteville, North Carolina
Lankenau Medical Center
Wynnewood, Pennsylvania
Tennessee Oncology, PLLC
Chattanooga, Tennessee
Tennessee Oncology
Nashville, Tennessee
Texas Oncology - Central South
Austin, Texas
Texas Oncology - Presbyterian Cancer Center
Dallas, Texas
Texas Oncology - Northeast Texas
Longview, Texas
Joe Arrington Cancer Research and Treatment Center at Covenant Children's Hospital
Lubbock, Texas
Texas Oncology - San Antonio
New Braunfels, Texas
Texas Oncology - DFW
Plano, Texas
Fred Hutchinson Cancer Center
Seattle, Washington
Hospital Aleman
Caba, Argentina
Fundacion CENIT
CABA, Argentina
Instituto Oncologico de Cordoba (IONC)
Córdoba, Argentina
Centro Privado de MRI de Rio Cuarto SA
Córdoba, Argentina
Sanatorio Allende
Córdoba, Argentina
Instituto Medico de la Fundacion Estudios Clinicos
Rosario, Santa Fe Province, Argentina
Instituto de Educacao, Pesquisa e Gestao em Saude
Rio de Janeiro, Brazil
Centro de Estudos e Pesquisa de Hematologia e Oncologia
Santo André, Brazil
Fundacao Pio XII - Hospital de Amor Barretos
São Paulo, Brazil
Centro Regional Integrado de Oncologia
Fortaleza, Ceará, Brazil
Hospital Araujo Jorge
Goiânia, Goiás, Brazil
Hospital do Cancer de Londrina
Londrina, Paraná, Brazil
Irmandade Santa Casa de Misericordia de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Uniao Brasileira de Educacao e Assistencia
Porto Alegre, Rio Grande do Sul, Brazil
Hospital de Amor Amazonia
Porto Velho, Rondônia, Brazil
Unique Hospital Multispecialty & Research Institute
Surat, Gujarat, India
SRV AGADI Hospital and Research Centre
Bangalore, Karnataka, India
Oncoville Cancer Hospital and Research Centre
Bengaluru, Karnataka, India
Mysore Medical College and Research Institute
Mysore, Karnataka, India
KIMS - Kingsway Hospitals
Nagpur, Maharashtra, India
Indrayani Hospital and Cancer Institute
Pune, Maharashtra, India
Erode Cancer Centre Private Ltd.
Erode, Tamil Nadu, India
Swami Harshankaranand Ji Hospital & Research Centre
Varanasi, Uttar Pradesh, India
Showing 40 of 46 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.